BACKGROUND: Alcohol consumption is strongly associated with cigarette smoking in young adults. PURPOSE: The aim of this study was to evaluate the acceptability and estimate the magnitude of the effect of a novel-integrated smoking cessation and binge-drinking intervention for young adults compared with standard treatment control. METHODS:Participants were 41 young adult smokers (≥ 10 cigarettes per day) who regularly (≥ 2 times per month) binge drank who were randomly assigned to standard treatment (n = 19) involving eight individual treatment visits plus 8 weeks of nicotine patch therapy or the identical smoking cessation treatment integrated with a binge-drinking intervention (integrated intervention; n = 22). RESULTS: Participants rated integrated intervention as highly acceptable as indicated by 100% of participants rating helpfulness as 5 on 5-point scale. Using an intent-to-treat analysis for tobacco abstinence, at both week 12 end of treatment and week 24 follow-up, more participants who received integrated intervention were biochemically confirmed abstinent from tobacco than those who received standard treatment (36% vs. 21% at week 12; 23% vs. 11% at week 24). At week 24, change from baseline in binge-drinking episodes, drinks consumed, and drinking days between treatment groups were similar (intent-to-treat analysis was not used for alcohol data). CONCLUSIONS: Preliminary data support the intriguing possibility that integrated intervention may enhance smoking cessation and reduce binge drinking.
RCT Entities:
BACKGROUND:Alcohol consumption is strongly associated with cigarette smoking in young adults. PURPOSE: The aim of this study was to evaluate the acceptability and estimate the magnitude of the effect of a novel-integrated smoking cessation and binge-drinking intervention for young adults compared with standard treatment control. METHODS:Participants were 41 young adult smokers (≥ 10 cigarettes per day) who regularly (≥ 2 times per month) binge drank who were randomly assigned to standard treatment (n = 19) involving eight individual treatment visits plus 8 weeks of nicotine patch therapy or the identical smoking cessation treatment integrated with a binge-drinking intervention (integrated intervention; n = 22). RESULTS:Participants rated integrated intervention as highly acceptable as indicated by 100% of participants rating helpfulness as 5 on 5-point scale. Using an intent-to-treat analysis for tobacco abstinence, at both week 12 end of treatment and week 24 follow-up, more participants who received integrated intervention were biochemically confirmed abstinent from tobacco than those who received standard treatment (36% vs. 21% at week 12; 23% vs. 11% at week 24). At week 24, change from baseline in binge-drinking episodes, drinks consumed, and drinking days between treatment groups were similar (intent-to-treat analysis was not used for alcohol data). CONCLUSIONS: Preliminary data support the intriguing possibility that integrated intervention may enhance smoking cessation and reduce binge drinking.
Authors: Christopher W Kahler; Jane Metrik; Heather R LaChance; Susan E Ramsey; David B Abrams; Peter M Monti; Richard A Brown Journal: J Consult Clin Psychol Date: 2008-10
Authors: Ivana T Croghan; Judith A Trautman; Theresa Winhusen; Jon O Ebbert; Frankie B Kropp; Darrell R Schroeder; Richard D Hurt Journal: Contemp Clin Trials Date: 2012-03-03 Impact factor: 2.226
Authors: Maria Orlando Edelen; Brian D Stucky; Mark Hansen; Joan S Tucker; William G Shadel; Li Cai Journal: Nicotine Tob Res Date: 2014-09 Impact factor: 4.244
Authors: Andrea C Villanti; Julia C West; Elias M Klemperer; Amanda L Graham; Darren Mays; Robin J Mermelstein; Stephen T Higgins Journal: Am J Prev Med Date: 2020-05-14 Impact factor: 5.043
Authors: Julia C West; Catherine Peasley-Miklus; Amanda L Graham; Darren Mays; Robin Mermelstein; Stephen T Higgins; Andrea C Villanti Journal: Addict Behav Date: 2020-05-26 Impact factor: 4.591
Authors: James M Davis; David M Mills; Kristin A Stankevitz; Alison R Manley; Matthew R Majeskie; Stevens S Smith Journal: BMC Complement Altern Med Date: 2013-09-03 Impact factor: 3.659
Authors: Severin Haug; Raquel Paz Castro; Andreas Filler; Tobias Kowatsch; Elgar Fleisch; Michael P Schaub Journal: BMC Public Health Date: 2014-11-05 Impact factor: 3.295
Authors: Severin Haug; Michael P Schaub; Corina Salis Gross; Ulrich John; Christian Meyer Journal: BMC Public Health Date: 2013-05-15 Impact factor: 3.295